Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery center? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies.

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is a safe and effective procedure that can be performed as an outpatient procedure. OBJECTIVES: The aim of the study was to determine whether same-day discharge LSG is safe when performed in an outpatient surgery center. SETTING: Outpatient surgery centers. METHODS: The medical records of 3162 patients who underwent primary LSG procedure by 21 surgeons at 9 outpatient surgery centers from January 2010 through February 2018 were retrospectively reviewed. RESULTS: Three thousand one hundred sixty-two patients were managed with enhanced recovery after surgery protocol and were included in this analysis. The mean age and preoperative body mass index were 43.1 ± 10.8 years and 42.1 ± 7.1 kg/m2, respectively. Sleep apnea, type 2 diabetes, gastroesophageal reflux disease, hypertension, and hyperlipidemia were seen in 14.4%, 13.5%, 24.7%, 30.4%, and 17.6% patients, respectively. The mean total operative time was 56.4 ± 16.9 minutes (skin to skin). One intraoperative complication (.03%) occurred. The hospital transfer rate was .2%. The 30-day follow-up rate was 85%. The postoperative outcomes were analyzed based on the available data. The 30-day readmission, reoperation, reintervention, and emergency room visit rates were .6%, .6%, .2%, and .1%, respectively. The 30-day mortality rate was 0%. The total short-term complication rate was 2.5%. CONCLUSIONS: Same-day discharge seems to be safe when performed in an outpatient surgery center in selected patients. It would appear that outpatient surgery centers are a viable option for patients with minimal surgical risks.

The changing paradigm for the treatment of colonic hemorrhage: superselective angiographic embolization.

PURPOSE: Colonic bleeding has historically been controlled by the use of localization procedures and surgery. Since our initial experience with superselective embolization of colonic bleeding, it has become our preferred method for the control of lower gastrointestinal hemorrhage. This follow-up study evaluates the Hartford Hospital experience using angiographic methods as the primary modality for the treatment of colonic bleeding. METHODS: From March 1993 to September 1999, 27 patients who had angiographically visualized colonic hemorrhage underwent arterial embolization procedures. Diagnostic arteriography was performed in all patients using digital subtraction imaging and selective contrast injections into the superior and inferior mesenteric arteries. Once the bleeding site was identified, superselective arteriogram and embolization was performed. Platinum-fibered coils, Hilal coils, or polyvinyl alcohol particle emboli were then fluoroscopically guided into the bleeding vessel. A repeat arteriogram was performed to confirm occlusion and the absence of any collateral channels. RESULTS: All 27 patients were initially controlled with arterial embolization; 6 patients rebled (22.2 percent), and 5 of these patients required surgery. Two patients demonstrated ischemia (7.4 percent), one of which required surgical intervention. The other patient was followed up by colonoscopy. There was no mortality in this study. CONCLUSION: Superselective embolization is effective in controlling colonic hemorrhage and is associated with a low rate of postembolization ischemia. Our experience with angiography reinforces the paradigm shift from its use as a diagnostic tool to the primary method for the control of colonic bleeding. Because patients have been followed up for as long as seven years, this approach remains effective for the long-term treatment of colonic bleeding.